Geert Jan Groeneveld (Geert J Groeneveld)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 48

Top Topics

Transcranial Magnetic Stimulation

Muscular Dystrophy

Top Venues

Clinical and translational science

British journal of clinical pharmacology

Movement disorders : official journal of the Movement Disorder Society

This page only lists publications with an associated author ORCID identifier.

Publications

Ingrid W Koopmans, Daphne Geerse, Lara de Ridder, Melvyn Roerdink, Maria Joanna Juachon, Clemens Muehlan, Jasper Dingemanse, Joop M A Van Gerven, Geert Jan Groeneveld, Rob G J A Zuiker
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant. Clinical and translational science 17 (7) (2024)
Yvonne Boyle, Hemme J Hijma, Jamie Rees, Jagtar Nijjar, Eirini Panoilia, Yolanda Alvarez, Sarah Siederer, Emma Greening, Edward C Emery, Kathy Abbott Banner, Geert Jan Groeneveld
Randomized, placebo-controlled study on the effects of intravenous GSK3858279 (anti-CCL17) on a battery of evoked pain tests in healthy participants. Clinical and translational science 17 (9) (2024)
Marella C E van Ruissen, Sebastiaan J W van Kraaij, Pim Gal, Wouter A Bakker, Hemme J Hijma, Geert Jan Groeneveld, Marieke L de Kam, Jacobus Burggraaf, Matthijs Moerland
Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat Stress. Journal of experimental pharmacology 16 (2024)
Sebastiaan J W van Kraaij, Rainer-Georg Goeldner, Holger Rosenbrock, Geert Jan Groeneveld, Philip Kremer, Jennifer Schaible, Janos Zambori, Christian Schultheis
Effects of the phosphodiesterase 2 inhibitor BI 474121 on central nervous system cyclic guanosine monophosphate concentrations: Translational studies. British journal of clinical pharmacology (2024)
Eva Thijssen, Bert Tuk, Michel Cakici, Veerle van Velze, Erica Surya Klaassen, Frans Merkus, Teus van Laar, Philip H C Kremer, Geert Jan Groeneveld
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients. Clinical and translational science 17 (5) (2024)
Martin Skov, Titia Q Ruijs, Thomas S Grønnebæk, Marianne Skals, Anders Riisager, Jeppe Blichfeldt Winther, Kamilla Løhde Tordrup Dybdahl, Anders Findsen, Jeanette J Morgen, Nete Huus, Martin Broch-Lips, Ole B Nielsen, Catherine M K E de Cuba, Jules A A C Heuberger, Marieke L de Kam, Martijn R Tannemaat, Jan J G M Verschuuren, Lars J S Knutsen, Nicholas M Kelly, Klaus G Jensen, William David Arnold, Arthur H M Burghes, Claus Olesen, Jane Bold, Thomas K Petersen, Jorge A Quiroz, John Hutchison, Eva R Chin, Geert Jan Groeneveld, Thomas Holm Pedersen
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis. Science translational medicine 16 (739) (2024)
Andriy A Gorbenko, Jules A A C Heuberger, Linda E Klumpers, Marieke L de Kam, Pamela K Strugala, Saco J de Visser, Geert Jan Groeneveld
Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ 9 -Tetrahydrocannabinol Without Improving Its Analgesic Properties. Clinical pharmacology and therapeutics (2024)
Ingrid W Koopmans, Daphne Geerse, Lara de Ridder, Melvyn Roerdink, Maria Joanna Juachon, Clemens Muehlan, Jasper Dingemanse, Joop M A Van Gerven, Geert Jan Groeneveld, Rob G J A Zuiker
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant. Clinical and translational science 17 (7) (2024)
Eva Thijssen, Bert Tuk, Michel Cakici, Veerle van Velze, Erica Surya Klaassen, Frans Merkus, Teus van Laar, Philip H C Kremer, Geert Jan Groeneveld
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients. Clinical and translational science 17 (5) (2024)
Eva Thijssen, Bert Tuk, Michel Cakici, Veerle van Velze, Erica Surya Klaassen, Frans Merkus, Teus van Laar, Philip H C Kremer, Geert Jan Groeneveld
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients. Clinical and translational science 17 (5) (2024)
Martin Skov, Titia Q Ruijs, Thomas S Grønnebæk, Marianne Skals, Anders Riisager, Jeppe Blichfeldt Winther, Kamilla Løhde Tordrup Dybdahl, Anders Findsen, Jeanette J Morgen, Nete Huus, Martin Broch-Lips, Ole B Nielsen, Catherine M K E de Cuba, Jules A A C Heuberger, Marieke L de Kam, Martijn R Tannemaat, Jan J G M Verschuuren, Lars J S Knutsen, Nicholas M Kelly, Klaus G Jensen, William David Arnold, Arthur H M Burghes, Claus Olesen, Jane Bold, Thomas K Petersen, Jorge A Quiroz, John Hutchison, Eva R Chin, Geert Jan Groeneveld, Thomas Holm Pedersen
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis. Science translational medicine 16 (739) (2024)
Ingrid W Koopmans, Daphne Geerse, Lara de Ridder, Melvyn Roerdink, Maria Joanna Juachon, Clemens Muehlan, Jasper Dingemanse, Joop M A Van Gerven, Geert Jan Groeneveld, Rob G J A Zuiker
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant. Clinical and translational science 17 (7) (2024)
Martin Skov, Titia Q Ruijs, Thomas S Grønnebæk, Marianne Skals, Anders Riisager, Jeppe Blichfeldt Winther, Kamilla Løhde Tordrup Dybdahl, Anders Findsen, Jeanette J Morgen, Nete Huus, Martin Broch-Lips, Ole B Nielsen, Catherine M K E de Cuba, Jules A A C Heuberger, Marieke L de Kam, Martijn R Tannemaat, Jan J G M Verschuuren, Lars J S Knutsen, Nicholas M Kelly, Klaus G Jensen, William David Arnold, Arthur H M Burghes, Claus Olesen, Jane Bold, Thomas K Petersen, Jorge A Quiroz, John Hutchison, Eva R Chin, Geert Jan Groeneveld, Thomas Holm Pedersen
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis. Science translational medicine 16 (739) (2024)
Maurits F J M Vissers, Matthew D Troyer, Eva Thijssen, Jules A A C Heuberger, Geert Jan Groeneveld, Sarah Huntwork-Rodriguez
A Leucine-Rich Repeat Kinase 2 (LRRK2) Pathway Biomarker Characterization Study in Patients with Parkinson's Disease with and without LRRK2 Mutations and Healthy Controls. Clinical and translational science (2023)
Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers, Vinay M Daryani, Dolores Diaz, Marisa S Goo, John J Chen, Romeo D Maciuca, Kyle Fraser, Omar S Mabrouk, Jeroen van de Wetering de Rooij, Jules A A C Heuberger, Geert Jan Groeneveld, Marie T Borin, Andrés Cruz-Herranz, Danielle Graham, Kimberly A Scearce-Levie, Javier De Vicente, Anastasia G Henry, Peter Chin, Carole Ho, Matthew D Troyer
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society (2023)
Ingrid W Koopmans, Robert-Jan Doll, Hein van der Wall, Marieke de Kam, Geert Jan Groeneveld, Adam Cohen, Rob Zuiker
Fit for purpose of on-the-road driving and simulated driving: A randomised crossover study using the effect of sleep deprivation. PloS one 18 (2) (2023)
Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers, Vinay M Daryani, Dolores Diaz, Marisa S Goo, John J Chen, Romeo D Maciuca, Kyle Fraser, Omar S Mabrouk, Jeroen van de Wetering de Rooij, Jules A A C Heuberger, Geert Jan Groeneveld, Marie T Borin, Andrés Cruz-Herranz, Danielle Graham, Kimberly A Scearce-Levie, Javier De Vicente, Anastasia G Henry, Peter Chin, Carole Ho, Matthew D Troyer
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society 38 (3) (2023)
Ahnjili Zhuparris, Ghobad Maleki, Ingrid W Koopmans, Robert-Jan Doll, Nicoline B M Voet, Wessel Kraaij, Adam A Cohen, Emilie M J van Brummelen, Joris H De Maeyer, Geert Jan Groeneveld
Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study. JMIR formative research 7 (2023)
Sebastiaan J W van Kraaij, Pim Gal, Laura G J M Borghans, Erica Surya Klaassen, Francis Dijkstra, Christopher Winrow, Chad Glasser, Geert Jan Groeneveld
First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator. Clinical and translational science (2023)
Ahnjili Zhuparris, Ghobad Maleki, Ingrid W Koopmans, Robert-Jan Doll, Nicoline B M Voet, Wessel Kraaij, Adam A Cohen, Emilie M J van Brummelen, Joris H De Maeyer, Geert Jan Groeneveld
Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study. JMIR formative research 7 (2023)
Ahnjili Zhuparris, Annika A de Goede, Iris E Yocarini, Wessel Kraaij, Geert Jan Groeneveld, Robert Jan Doll
Machine Learning Techniques for Developing Remotely Monitored Central Nervous System Biomarkers Using Wearable Sensors: A Narrative Literature Review. Sensors (Basel, Switzerland) 23 (11) (2023)
Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers, Vinay M Daryani, Dolores Diaz, Marisa S Goo, John J Chen, Romeo D Maciuca, Kyle Fraser, Omar S Mabrouk, Jeroen van de Wetering de Rooij, Jules A A C Heuberger, Geert Jan Groeneveld, Marie T Borin, Andrés Cruz-Herranz, Danielle Graham, Kimberly A Scearce-Levie, Javier De Vicente, Anastasia G Henry, Peter Chin, Carole Ho, Matthew D Troyer
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society 38 (3) (2023)
Ingrid W Koopmans, Robert-Jan Doll, Hein van der Wall, Marieke de Kam, Geert Jan Groeneveld, Adam Cohen, Rob Zuiker
Fit for purpose of on-the-road driving and simulated driving: A randomised crossover study using the effect of sleep deprivation. PloS one 18 (2) (2023)
Sebastiaan J W van Kraaij, Pim Gal, Laura G J M Borghans, Erica Surya Klaassen, Francis Dijkstra, Christopher Winrow, Chad Glasser, Geert Jan Groeneveld
First-in-human trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator. Clinical and translational science (2023)
Ingrid W Koopmans, Robert-Jan Doll, Hein van der Wall, Marieke de Kam, Geert Jan Groeneveld, Adam Cohen, Rob Zuiker
Fit for purpose of on-the-road driving and simulated driving: A randomised crossover study using the effect of sleep deprivation. PloS one 18 (2) (2023)
Ahnjili Zhuparris, Eva Thijssen, Willem O Elzinga, Soma Makai-Bölöni, Wessel Kraaij, Geert Jan Groeneveld, Robert-Jan Doll
Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks. Movement disorders : official journal of the Movement Disorder Society (2023)
Ingrid W Koopmans, Robert-Jan Doll, Hein van der Wall, Marieke de Kam, Geert Jan Groeneveld, Adam Cohen, Rob Zuiker
Fit for purpose of on-the-road driving and simulated driving: A randomised crossover study using the effect of sleep deprivation. PloS one 18 (2) (2023)
Sebastiaan J W van Kraaij, Laura G J M Borghans, Erica S Klaassen, Pim Gal, Jeroen van der Grond, Ken Tripp, Christopher Winrow, Chad Glasser, Geert Jan Groeneveld
Randomized placebo-controlled crossover study to assess tolerability and pharmacodynamics of zagociguat, a soluble guanylyl cyclase stimulator, in healthy elderly. British journal of clinical pharmacology (2023)
Maurits F J M Vissers, Matthew D Troyer, Eva Thijssen, Jules A A C Heuberger, Geert Jan Groeneveld, Sarah Huntwork-Rodriguez
A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls. Clinical and translational science (2023)
Laurence Moss, Hemme Hijma, Mark Demitrack, Jessica Kim, Geert Jan Groeneveld, Monique van Velzen, Marieke Niesters, Erik Olofsen, Albert Dahan
Neurocognitive effect of biased µ-opioid receptor agonist oliceridine, a utility function analysis and comparison with morphine. Anesthesiology (2023)
Anne Catrien Baakman, Carmen Gavan, Lotte van Doeselaar, Marieke de Kam, Karen Broekhuizen, Ovidiu Bajenaru, Laura Camps, Eleonora L Swart, Kees Kalisvaart, Niki Schoonenboom, Evelien Lemstra, Philip Scheltens, Adam Cohen, Joop M A Van Gerven, Geert Jan Groeneveld
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease. British journal of clinical pharmacology 88 (6) (2022)
Titia Q Ruijs, Ingrid W Koopmans, Marieke L de Kam, Michiel J van Esdonk, Martin Koltzenburg, Geert Jan Groeneveld, Jules A A C Heuberger
Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Clinical pharmacology and therapeutics 112 (5) (2022)
Eva Thijssen, Jonas M den Heijer, David Puibert, Laurence Moss, Mingzu Lei, David Hasegawa, Kyo Keum, Ken Mochel, Mohammed Ezzeldin Sharaf, Tom Alfredson, Wenxiang Zeng, Emilie van Brummelen, Tatjana Naranda, Geert Jan Groeneveld
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009. Movement disorders : official journal of the Movement Disorder Society 37 (4) (2022)
Boudewijn van den Berg, Hemme J Hijma, Ingrid Koopmans, Robert-Jan Doll, Rob G J A Zuiker, Geert Jan Groeneveld, Frans C T van der Helm
Simultaneous measurement of intra-epidermal electric detection thresholds and evoked potentials for observation of nociceptive processing following sleep deprivation. Experimental brain research 240 (2) (2022)
Hemme J Hijma, Ingrid Koopmans, Erica Klaassen, Robert Jan Doll, Rob G J A Zuiker, Geert Jan Groeneveld
A crossover study evaluating the sex-dependent and sensitizing effects of sleep deprivation using a nociceptive test battery in healthy subjects. British journal of clinical pharmacology (2022)
Maurits F J M Vissers, Jules A A C Heuberger, Geert Jan Groeneveld, Jerome Oude Nijhuis, Peter Paul De Deyn, Salah Hadi, Jeffrey Harris, Richard M Tsai, Andres Cruz-Herranz, Fen Huang, Vincent Tong, Rebecca Erickson, Yuda Zhu, Kimberly Scearce-Levie, Jennifer Hsiao-Nakamoto, Xinyan Tang, Megan Chang, Brian M Fox, Anthony A Estrada, Robert J Pomponio, Miguel Alonso-Alonso, Moshe Zilberstein, Nazem Atassi, Matthew D Troyer, Carole Ho
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients. Clinical and translational science 15 (8) (2022)
Titia Q Ruijs, Jules A A C Heuberger, Annika A de Goede, Dimitrios Ziagkos, Marije E Otto, Robert-Jan Doll, Michel J A M van Putten, Geert Jan Groeneveld
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study. British journal of clinical pharmacology 88 (6) (2022)
Marcus P J van Diemen, Dimitrios Ziagkos, Matthijs D Kruizinga, Menno R Bénard, Philip Lambrechtse, Joris A J Jansen, Barbara A M Snoeker, Maaike G J Gademan, Adam A Cohen, Rob R G H H Nelissen, Geert Jan Groeneveld
Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty. Clinical and translational science (2022)
Ghobad Maleki, Ahnjili Zhuparris, Ingrid W Koopmans, Robert-Jan Doll, Nicoline B M Voet, Adam A Cohen, Emilie M J van Brummelen, Geert Jan Groeneveld, Joris H De Maeyer
Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study. JMIR formative research 6 (9) (2022)
Titia Q Ruijs, Ingrid W Koopmans, Marieke L de Kam, Martijn R Tannemaat, Geert Jan Groeneveld, Jules A A C Heuberger
Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double-blind placebo-controlled cross-over study. Clinical and translational science (2022)
Eva Thijssen, Soma Makai-Bölöni, Emilie van Brummelen, Jonas M den Heijer, Yalcin Yavuz, Robert-Jan Doll, Geert Jan Groeneveld
A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease. Movement disorders clinical practice 9 (8) (2022)
Soma Makai-Bölöni, Eva Thijssen, Emilie M J van Brummelen, Geert Jan Groeneveld, Robert J Doll
Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance. PloS one 16 (12) (2021)
Kawita M S Kanhai, Sebastiaan C Goulooze, Jeroen van der Grond, Amy C Harms, Thomas Hankemeier, Ajay Verma, Gersham Dent, Juan Chavez, Henri Meijering, Geert Jan Groeneveld
Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis. Clinical and translational science (2021)
Laurence M Moss, Cécile L Berends, Emilie M J van Brummelen, Ingrid M C Kamerling, Erica S Klaassen, Kirsten Bergmann, Vanessa Ville, Victor Juarez-Perez, Annie-Claude Benichou, Geert Jan Groeneveld
First-in-human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR-324, a dual enkephalinase inhibitor for pain management. British journal of clinical pharmacology (2021)
Willem O Elzinga, Samantha Prins, Laura G J M Borghans, Pim Gal, Gabriel A Vargas, Geert Jan Groeneveld, Robert-Jan Doll
Detection of Clenbuterol-Induced Changes in Heart Rate Using At-Home Recorded Smartwatch Data: Randomized Controlled Trial. JMIR formative research 5 (12) (2021)
Jonas M den Heijer, Jacobus J van Hilten, Anneke J A Kievit, Vincenzo Bonifati, Geert Jan Groeneveld
Experience in Genetic Counseling for GBA1 Variants in Parkinson's Disease. Movement disorders clinical practice 8 (1) (2020)
Igor Radanovic, Robert Likić, Geert Jan Groeneveld
Spotlight Commentary: Importance of dose redefining in the process of drug repurposing. British journal of clinical pharmacology 87 (4) (2020)
Jolien Fleur Leijenaar, Geert Jan Groeneveld, Wiesje Maria van der Flier, Philip Scheltens, Erica Surya Klaassen, Henry Chanoch Weinstein, Geert Jan Biessels, Frederik Barkhof, Niels Daniël Prins
Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial. JMIR research protocols 7 (3) (2018)